LIM 2550
Human colon carcinoma.
[Create a profile and sign in to view pricing and add to cart]
- Description
- Ask a Question
Description
Description: Colon carcinoma
Description Key Words: Human colon carcinoma
Also Known As: No other names
Organism: Human (Homo sapiens)
Strain: N/A
Tissue: Colon
Growth Properties: Cell line grows as floating and loose aggregates with some adherent cells.
Morphology: Epithelial
Growth Medium: RPMI1640 (with 2mM L-Glutamine + 25mM HEPES) + 10% Foetal Calf Serum (FCS) + Insulin 0.6μg/ml, Hydrocortisone 1μg/ml, 1-Thioglycerol 10μM.
Resuscitation: Remove protective cryoflex layer around the ampoule prior to thawing. Thaw the ampoule by gently agitating in a 37°C waterbath; thawing should be rapid (around 2 minutes). A centrifugation step to remove the cryoprotectant after thawing is necessary for this cell line.
Subculturing Procedure:
Medium Renewal: 3 times each week. Feed and passage as for semi-adherent culture (collect medium with floating cells and then trypsinise the adherent population pool both together before reseeding).
Subcultivation Ratio: 1:4 – 1:8 Seeding density 1 – 2 x104 cells/cm2. Split sub-confluent cultures (70-80%). Harvest the cells using 0.05% Trypsin/EDTA at 37°C for 5 minutes. Cells may take 2-3 days to seed after thawing or trypsinisation.
Culture Conditions: Cells maintained at 37°C and 5% CO2.
Cryoprotectant Medium: 10% DMSO + 90% FCS
Handling Procedure for Frozen Cells: Upon receipt, frozen ampoules should be transferred directly to liquid nitrogen storage without delay, if not to be used immediately. Storage at -80°C may result in loss of viability.
Additional Information: Derived from colon carcinoma, adherent and loose aggregates
MSI, A33 negative, truncated APC (stop at aa 1544)
Mutated p53 (aa G245D)
Heterozygous mutated K-Ras (aa Q61H)
Mutated PI3K (aa H1047R p110alpha).
Depositor: Professor Tony Burgess – Ludwig Institute for Cancer Research Ltd, Melbourne, Australia
Reference:
Zhang H. et al.
Selective inhibition of proliferation in colorectal carcinoma cell lines expressing mutant APC or activated B-Raf
Int.J.Cancer 2009 July15; 125(2):297-307
PubMed 19378335
Cellosaurus: CVCL_4442
Ask a Question
Have a question about this product? Our technical team is here to help.




